Alin Popescu

Get in Touch

vCard LinkedIn

Alin Popescu

Alin Popescu serves as partner and is a member of the Industrial, Life Science and Consumer Practice Groups. Read more >

Alin Popescu serves as partner and is a member of the Industrial, Life Science and Consumer Practice Groups.

Alin has twenty years of experience in executive search in the CEE region, covering a wide range of industries including consumer goods & retail, industry & energy, financial services, pharmaceuticals and technology.

Prior to joining DHR, Alin served as partner at CTPartners NEUMANN. Alin joined CTPartners in 2014, when the firm merged with Neumann Partners.

Previously, Alin was a partner with Neumann Partners. He was based in the Bucharest office and he successfully handled executive search assignments across the CEE & CIS region for clients in numerous industries. 

Alin entered the executive search business at the very early stage of the CEE market (1995), and has been part of its various development phases. During this period, he has accumulated a vast knowledge of the CEE region and experience in placing executives in key roles in many different business sectors.

Alin studied Civil and Environmental Engineering as well as Project Management.  He is fluent in English, French, and Romanian.  

  < Read less



Bucharest | Europe
Sofia | Europe
July 2016 | White Papers

The Pharmaceutical Industry Increasingly Looking Inwards for Leadership Roles Despite Significant Challenges on the Horizon

Shareholders and management consultants have often expressed the concern that the pharmaceutical industry has been hiring for key leadership roles from a restricted pool of company insiders or shortlist of pharmaceutical industry veterans. While this has given the boards of these companies deep scientific and technical expertise it may have slowed the industry’s development by inhibiting growth of a broader skillset. More >

July 2016 | The Pharma Letter

Today’s pharma leaders are less experienced in other sectors, but does it matter?

The pharmaceutical industry’s use of directors from outside the sector has fallen from 40% to 26% in the last five years, research from executive search firm DHR International shows. More >